Interclean Shanghai

Zoll Medical announced Zoll LifeVest Wearable Defibrillator is now covered by Medical Assistance(MA)

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced that the ZOLL LifeVest® Wearable Defibrillator is now covered by Medical Assistance (MA), Minnesota’s Medicaid program.

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced that the ZOLL LifeVest® Wearable Defibrillator is now covered by Medical Assistance (MA), Minnesota’s Medicaid program. MA is the largest of the state’s health care programs, providing health care coverage and prescription coverage to a monthly average of 507,000 low-income senior citizens, children and families, and people with disabilities.    

LifeVest is typically worn for two to three months by patients at risk for sudden cardiac arrest (SCA), either while the decision is made to implant a cardiac defibrillator (ICD) or when an ICD may not be appropriate for the patient.  This 1.8 pound device is a vest with electrodes that is connected to a “walkman-sized” defibrillator worn on a belt.  It provides constant monitoring of the patient’s heart, immediate protection, and peace of mind, as it records data to help diagnose and treat life-threatening arrhythmias.

Richard A. Packer, President and Chief Executive Officer of ZOLL siad, Having the LifeVest now approved in Minnesota is another important step in bringing this technology to more patients.  As with many other potential life-saving treatments, it takes insurance coverage to make them accessible to more people who could benefit from them.

The LifeVest is specifically approved by Medicare and other insurers for those at high risk of cardiac arrest who can’t have immediate implant surgery for an ICD (implantable cardioverter defibrillator), including those recovering from infections.  

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »